HK36793A - Ketone derivatives as medicaments for the treatment or prevention of the withdrawal syndrome - Google Patents

Ketone derivatives as medicaments for the treatment or prevention of the withdrawal syndrome

Info

Publication number
HK36793A
HK36793A HK367/93A HK36793A HK36793A HK 36793 A HK36793 A HK 36793A HK 367/93 A HK367/93 A HK 367/93A HK 36793 A HK36793 A HK 36793A HK 36793 A HK36793 A HK 36793A
Authority
HK
Hong Kong
Prior art keywords
prevention
medicaments
treatment
withdrawal syndrome
ketone derivatives
Prior art date
Application number
HK367/93A
Other languages
English (en)
Inventor
Michael Brian Tyers
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of HK36793A publication Critical patent/HK36793A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK367/93A 1986-11-21 1993-04-15 Ketone derivatives as medicaments for the treatment or prevention of the withdrawal syndrome HK36793A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868627909A GB8627909D0 (en) 1986-11-21 1986-11-21 Medicaments

Publications (1)

Publication Number Publication Date
HK36793A true HK36793A (en) 1993-04-23

Family

ID=10607734

Family Applications (1)

Application Number Title Priority Date Filing Date
HK367/93A HK36793A (en) 1986-11-21 1993-04-15 Ketone derivatives as medicaments for the treatment or prevention of the withdrawal syndrome

Country Status (16)

Country Link
US (1) US4847281A (ja)
EP (1) EP0278161B1 (ja)
JP (1) JPH0830008B2 (ja)
KR (1) KR950010148B1 (ja)
AT (1) ATE74271T1 (ja)
AU (1) AU608788B2 (ja)
CY (1) CY1694A (ja)
DE (1) DE3778008D1 (ja)
DK (1) DK612787A (ja)
ES (1) ES2033879T3 (ja)
GB (1) GB8627909D0 (ja)
GR (1) GR3004252T3 (ja)
HK (1) HK36793A (ja)
IE (1) IE61033B1 (ja)
PH (1) PH24934A (ja)
ZA (1) ZA878702B (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3777805D1 (de) * 1986-11-21 1992-04-30 Glaxo Group Ltd Arzneimittel zur behandlung oder vorbeugung des entzugssyndromes.
US5198447A (en) * 1986-11-21 1993-03-30 Glaxo Group Limited Medicaments
DE3822792C2 (de) * 1987-07-11 1997-11-27 Sandoz Ag Neue Verwendung von 5HT¶3¶-Antagonisten
US5198459A (en) * 1987-07-11 1993-03-30 Sandoz Ltd. Use of 5HT-3 antagonists in preventing or reducing dependency on dependency-inducing agents
US5272168A (en) * 1987-07-11 1993-12-21 Sandoz Ltd. Use of 5HT-3 antagonists in preventing or reducing dependency on dependency-inducing agents
GB8820650D0 (en) * 1988-09-01 1988-10-05 Glaxo Group Ltd Medicaments
US5292752A (en) * 1989-12-21 1994-03-08 Merrell Dow Pharmaceuticals Inc. Antithrombotic compounds
US5225407A (en) * 1990-02-22 1993-07-06 Glaxo Group Limited 5-HT3 receptor antagonists for the treatment of autism
US5397782A (en) * 1990-06-13 1995-03-14 Janssen Pharmaceutica N.V. Method of treating addiction to alcohol
JPH06508836A (ja) * 1991-06-26 1994-10-06 セプラコア，インコーポレーテッド 光学的に純粋なｒ（＋）オンダンセトロンを使用する嘔吐、吐き気および他の障害の治療のための方法および組成物
GB9310756D0 (en) * 1993-05-25 1993-07-14 Glaxo Lab Sa Compositions
US5726644A (en) * 1995-06-30 1998-03-10 Philips Electronics North America Corporation Lighting control system with packet hopping communication
US5824684A (en) * 1997-02-21 1998-10-20 Synapse Pharmaceuticals International, Inc. Method for treating drug and alcohol addiction
US20080004260A1 (en) * 2006-06-29 2008-01-03 Transcept Pharmaceuticals, Inc. Compositions of 5-HT3 antagonists and dopamine D2 antagonists for treatment of dopamine-associated chronic conditions
CN102307895A (zh) * 2008-12-04 2012-01-04 里兰斯坦福初级大学理事会 用于治疗或预防麻醉药停药症状的方法和组合物
US20100298397A1 (en) * 2009-05-19 2010-11-25 Singh Nikhilesh N Method of treatment of obsessive compulsive disorder with ondansetron
US20110288115A1 (en) * 2010-05-24 2011-11-24 Avmedis Llc Treatment of vagally-mediated spectrum disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4499096A (en) * 1983-11-18 1985-02-12 Lotsof Howard S Rapid method for interrupting the narcotic addiction syndrome
IE57809B1 (en) * 1984-01-25 1993-04-21 Glaxo Group Ltd 1,2,3,9-tetrahydro-3-(imidazol-1-ylmethyl)-4h-carbazol-4 one derivatives
EP0201165B1 (en) * 1985-03-14 1994-07-20 Beecham Group Plc Medicaments for the treatment of emesis
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
HU895334D0 (en) * 1986-07-30 1990-01-28 Sandoz Ag Process for the preparation of nasal pharmaceutical compositions
PH23937A (en) * 1986-12-16 1990-01-23 Robins Co Inc A H Anxiolytic-n-(1-azabicyclo(2.2.2.)oct-3-yl)benzamides and thiobenzamides
DE3822792C2 (de) * 1987-07-11 1997-11-27 Sandoz Ag Neue Verwendung von 5HT¶3¶-Antagonisten

Also Published As

Publication number Publication date
IE61033B1 (en) 1994-09-07
JPH0830008B2 (ja) 1996-03-27
KR880005930A (ko) 1988-07-21
GR3004252T3 (ja) 1993-03-31
DK612787D0 (da) 1987-11-20
ES2033879T3 (es) 1995-04-01
GB8627909D0 (en) 1986-12-31
AU608788B2 (en) 1991-04-18
DK612787A (da) 1988-05-22
ZA878702B (en) 1988-09-28
JPS63185927A (ja) 1988-08-01
DE3778008D1 (de) 1992-05-07
AU8144387A (en) 1988-05-26
EP0278161A1 (en) 1988-08-17
ATE74271T1 (de) 1992-04-15
KR950010148B1 (ko) 1995-09-11
EP0278161B1 (en) 1992-04-01
CY1694A (en) 1994-01-14
PH24934A (en) 1990-12-26
IE873156L (en) 1988-05-21
US4847281A (en) 1989-07-11

Similar Documents

Publication Publication Date Title
HK36793A (en) Ketone derivatives as medicaments for the treatment or prevention of the withdrawal syndrome
EP0392959A3 (en) Use of sertindole for the treatment of schizophrenia
AU2711295A (en) Combination treatment for inhibiting bone loss
HU9603042D0 (en) Use of certain methanebisphosphonic acid derivatives to prevent or for treatment of prosthesis loosening and prosthesis migration
AU8261787A (en) Medicaments for the treatment of depression
GR3006091T3 (ja)
HU901085D0 (en) Process for producing substituted benzimidazole and pharmaceutical preparatives containing it
ZA925146B (en) Pharmaceutical agent for treatment of withdrawal symptoms.
IL88740A (en) Pharmaceutical compositions containing n-n-butyl deoxynojirimycin for treating aids
SE8902458D0 (sv) Laekemedelskomposition
IE873231L (en) Medicaments
ZA872443B (en) Bis-tert.butylamino-substituted 1,3,5-triazine derivatives,processes for their preparation,medicaments containing these compounds and their use
IL98199A0 (en) Pharmaceutical compositions containing a derivative of substituted-l-valyl-l-prolinamide
IT1296613B1 (it) Farmaco per la cura dell'ircismo contenente un adrenocorticosteroide.
EP0457336A3 (en) Use of mizoribine for the treatment or prevention of multiple sclerosis
IL89654A (en) Pharmaceutical combination compositions for treating hypertension
MX9803271A (es) Uso de la 1-(2-naft-2-iletil)-4-(3-trifluorometilfenil)-1,2,6-tetrahid ropiridina para la preparacion de farmacos para el tratamiento de esclerosis lateral aminotrofica.

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20041120